National Institute of General Medical Sciences; Notice of Meeting, 22606-22607 [2010-9987]

Download as PDF mstockstill on DSKH9S0YB1PROD with NOTICES 22606 Federal Register / Vol. 75, No. 82 / Thursday, April 29, 2010 / Notices PressAnnouncements/ucm202814.htm, March 3, 2010. 3. Flegal, K.M., M.D. Carroll, C.L. Ogden, et al.,‘‘Prevalence and Trends in Obesity Among U.S. Adults,’’ 1999 to 2008, Journal of the American Medical Association, 2010;303(3):235–241, Published online, (doi:10.1001/jama.2009.2014), January 13, 2010. 4. Ogden, C.L., M.D. Carroll, L.R. Curtin, et al., ‘‘Prevalence of High Body Mass Index in U.S. Children and Adolescents,’’ 2007 to 2008, Journal of the American Medical Association, 2010;303(3):242–249, Published online (doi:10.1001/jama.2009.2012), January 13, 2010. 5. Let’s Move, Available at https:// letsmove.gov/. 6. Smart Choices Program, Available at https://www.smartchoicesprogram.com/. 7. Kellogg Co., ‘‘Nutrition at a Glance,’’ Available at https://www.kelloggs nutrition.com/learn-about-labels/nutritionat-a-glance.html. 8. Food Standards Agency, ‘‘Traffic Light Labeling,’’ Available at https://www.eatwell. gov.uk/foodlabels/trafficlights/. 9. Livsmedelsverket, National Food Administration, ‘‘The Keyhole Symbol,’’ Available at https://www.slv.se/en-gb/Group1/ Food-and-Nutrition/Keyhole-symbol/. 10. Hannaford, ‘‘What is Guiding Stars?,’’ Available at https://www.hannaford.com/ Contents/Healthy_Living/Guiding_Stars/ index.shtml?lid=mb. 11. U.S. Department of Health and Human Services and U.S. Department of Agriculture, ‘‘Dietary Guidelines for Americans, 2005,’’ 6th ed., Washington, DC, U.S. Government Printing Office, January 2005, Available at https://www.health.gov/dietaryguidelines/ dga2005/document/. 12. FDA, ‘‘Food Labeling: Use of Symbols to Communicate Nutrition Information, Consideration of Consumer Studies and Nutritional Criteria; Public Hearing; Request for Comments,’’ (72 FR 39815, July 20, 2007), Available at https://edocket.access.gpo.gov/ 2007/pdf/E7-14046.pdf. 13. FDA, ‘‘Comments on Symbols Public Hearing and Current Plans for Addressing Issues,’’ Available at https:// www.regulations.gov/search/Regs/home. html#documentDetail?R=09000064809623e8, April 21, 2009. 14. FDA, ‘‘Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Nutrition Symbols on Food Packages,’’ (74 FR 26244, June 1, 2009), Available at https:// edocket.access.gpo.gov/2009/E9-12669.htm. 15. FDA, ‘‘Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Studies of Nutrition Symbols on Food Packages,’’ (74 FR 62786, December 1, 2009), Available at https:// edocket.access.gpo.gov/2009/E9-28699.htm. 16. Sutherland, L.A., L.A. Kaley, and L. Fischer, ‘‘Guiding Stars: The Effect of a Nutrition Navigation Program on Consumer Purchases at the Supermarket,’’ American Journal of Clinical Nutrition, Available at https://www.ajcn.org/cgi/content/abstract/ ajcn.2010.28450Cv1, February 10, 2010. 17. Malam, S., S. Clegg, S. Kirwin, et al., ‘‘Comprehension and Use of UK Nutrition VerDate Mar<15>2010 16:19 Apr 28, 2010 Jkt 220001 Signpost Labelling Schemes,’’ British Market Research Bureau, Available at https:// www.food.gov.uk/multimedia/pdfs/ pmpreport.pdf, 2009. 18. Kelly, B., C. Hughes, K. Chapman, et al., ‘‘Consumer Testing of the Acceptability and Effectiveness of Front-of-Pack Food Labelling Systems for the Australian Grocery Market,’’ Health Promotion International, 24(2): 120–9, 2009. 19. Borgmeier I., and J. Westenhoefer, ‘‘Impact of Different Food Label Formats on Healthiness Evaluation and Food Choice of Consumers: A Randomized-Controlled Study,’’ BMC Public Health, 9: 184, 2009. 20. Feunekes, G.I., I.A. Gortemaker, A.A. Willems, et al., ‘‘Front-of-Pack nutrition Labelling: Testing Effectiveness of Different Nutrition Labelling Formats Front-of-Pack in Four European Countries,’’ Appetite, 50(1): 57–70, 2008. 21. Which?, ‘‘Healthy Signs?,’’ Campaign Report, London, United Kingdom, Available at https://www.which.co.uk/documents/pdf/ healthy-signs--which---campaign-report-176909.pdf, 2006. 22. Food Standards Agency, Quantitative Evaluation of Alternative Food Signposting Concepts: Report of Findings, London, United Kingdom, Available at https:// www.food.gov.uk/multimedia/pdfs/signpost quanresearch.pdf, 2005. 23. Young, L., and B. Swinburn, ‘‘Impact of the Pick the Tick Food Information Programme on the Salt Content of Food in New Zealand,’’ Health Promotion International 17(1): 13–9, 2002. 24. Scott, V. and A.F. Worsley, ‘‘Ticks, Claims, Tables and Food Groups: A Comparison for Nutrition Labelling,’’ Health Promotion International, 9(1): 27–37, 1994. 25. General Mills, ‘‘Nutrition Highlights,’’ Available at https://www.generalmills.com/ corporate/health_wellness/nutrition_ highlights.aspx. 26. American Heart Association, ‘‘HeartCheck Mark,’’ Available at https:// www.americanheart.org/presenter. jhtml?identifier=2115. Dated: April 26, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2010–9939 Filed 4–26–10; 11:15 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory General Medical Sciences Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory General Medical Sciences Council. Date: May 20–21, 2010. Closed: May 20, 2010, 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892. Open: May 21, 2010, 8:30 a.m. to Adjournment. Agenda: For the discussion of program policies and issues, opening remarks, report of the Director, NIGMS, and other business of the Council. Place: National Institutes of Health, Natcher Building, Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892. Contact Person: Ann A. Hagan, PhD, Associate Director for Extramural Activities, NIGMS, NIH, DHHS, 45 Center Drive, Room 2AN24H, MSC6200, Bethesda, MD 20892– 6200, (301) 594–4499, hagana@nigms.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// www.nigms.nih.gov/about/ advisory_council.html, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, E:\FR\FM\29APN1.SGM 29APN1 Federal Register / Vol. 75, No. 82 / Thursday, April 29, 2010 / Notices Special Minority Initiatives, National Institutes of Health, HHS) Dated: April 23, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–9987 Filed 4–28–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Meetings mstockstill on DSKH9S0YB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Advisory Neurological Disorders and Stroke Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Neurological Disorders and Stroke Council, Clinical Trials Subcommittee. Date: May 26–27, 2010. Closed: May 26, 2010, 6:30 p.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Open: May 27, 2010, 8 a.m. to 9:30 a.m. Agenda: To discuss clinical trials policy. Place: National Institutes of Health, Building 31, 31 Center Drive, 6th Floor, Conference Room 10, Bethesda, MD 20892. Contact Person: Petra Kaufmann, MD, Director, Office of Clinical Research, NINDS, National Institutes of Health, Neuroscience Center, Room 2216, 6001 Executive Blvd. (301) 496–9135. Kaufmanp2@ninds.nih.gov. Name of Committee: National Advisory Neurological Disorders and Stroke Council, Basic and Preclinical Programs Subcommittee. VerDate Mar<15>2010 16:19 Apr 28, 2010 Jkt 220001 Date: May 27, 2010. Time: 8 a.m. to 9:30 a.m. Agenda: To discuss basic and preclinical policy. Place: National Institutes of Health, Building 31, 31 Center Drive, 6th Floor, Conference Room 7, Bethesda, MD 20892. Contact Person: William D. Matthew, PhD, Director, Office of Translational Research, NINDS, National Institutes of Health, Neuroscience Center, Room 2137, 6001 Executive Blvd. (301) 496–1779. Bill.Matthew@nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// www.ninds.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: April 23, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–9986 Filed 4–28–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Coordinating Center for Infectious Diseases (CCID) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the cancellation of the May 2010 meeting of the aforementioned board. Due to unanticipated circumstances and scheduling conflicts, the board does not have the quorum required to convene. Contact Person for More Information: Leola Mitchell, Office of the Director, CCID, CDC, 1600 Clifton Road, NE., Mailstop K–74, Atlanta, Georgia 30333, e-mail fvp9@cdc.gov, telephone (770) 488–8366. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 22607 meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 21 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–9953 Filed 4–28–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Board Public Meeting Times and Dates (All times are Eastern Time) 8:15 a.m.–4:30 p.m., May 19, 2010. 8:15 a.m.–6 p.m., May 20, 2010. 8:15 a.m.–12 p.m., May 21, 2010. Public Comment Times and Dates (All times are Eastern Time) 4:30 p.m.–6 p.m.,* May 19, 2010. 6 p.m.–7:30 p.m.,* May 20, 2010. *Please note that the public comment periods may end before the times indicated, following the last call for comments. Members of the public who wish to provide public comment should plan to attend public comment sessions at the start times listed. Place: Crowne Plaza Hotel, 300 3rd Street, Niagara Falls, New York; Phone: 716–285– 3361; Fax: 716–285–3900. Audio Conference Call via FTS Conferencing. The USA toll free dial in number is 1–866–659–0537 with a pass code of 9933701. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 200 people. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program (EEOICP) Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been E:\FR\FM\29APN1.SGM 29APN1

Agencies

[Federal Register Volume 75, Number 82 (Thursday, April 29, 2010)]
[Notices]
[Pages 22606-22607]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9987]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Advisory General Medical Sciences Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory General Medical Sciences 
Council.
    Date: May 20-21, 2010.
    Closed: May 20, 2010, 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 
Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892.
    Open: May 21, 2010, 8:30 a.m. to Adjournment.
    Agenda: For the discussion of program policies and issues, 
opening remarks, report of the Director, NIGMS, and other business 
of the Council.
    Place: National Institutes of Health, Natcher Building, 
Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892.
    Contact Person: Ann A. Hagan, PhD, Associate Director for 
Extramural Activities, NIGMS, NIH, DHHS, 45 Center Drive, Room 
2AN24H, MSC6200, Bethesda, MD 20892-6200, (301) 594-4499, 
hagana@nigms.nih.gov.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: https://www.nigms.nih.gov/about/advisory_council.html, where 
an agenda and any additional information for the meeting will be 
posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93.96,

[[Page 22607]]

Special Minority Initiatives, National Institutes of Health, HHS)

    Dated: April 23, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-9987 Filed 4-28-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.